P64 NIMBUS geometric clot extractor for tough clots: SPERO study results and clot composition

ConclusionsIn challenging cases with tough clot, first pass of NIMBUS retrieved clot richer in fibrin and lower in RBC content than clot retrieved with the first pass of standard MT devices.ReferencesFennell VS, Setlur Nagesh SV, Meess KM, Gutierrez L, James RH, Springer ME, Siddiqui AH. What to Do about Fibrin Rich ‘Tough Clots’? Comparing the Solitaire Stent Retriever with a Novel Geometric Clot Extractor in an in vitro Stroke Model. J Neurointerv Surg 2018 Sep;10(9):907–910. DOI: 10.1136/Neurintsurg-2017-013507. EPUB 2018 Jan 19. PMID: 29352061. Do you have any conflict of interest to declare?: YesConflict of Interest StatementDL – consultant: Genentech, Cerenovus, Medtronic, Stryker. FA – grants from Stryker, Cerenovus. FC – personal fees: Balt, Stryker, Artedrone. HD – research support: French Ministry of Health, Genavie Foundation, Société Francaise de Radiologie, Société Fracaise de Neuroradiologie. JHB – consultant fees: Microvention, Stryker, Cerenovus, Acandis, Medtronic. JT – consultant, stock: MicroVention. KD – holdings: Perfuze; research funding: Science Foundation Ireland that is cofunded by Cerenovus. MR – equity/advisory board: Methinks Software; cofounder: Anaconda Biomed; consultant: Methinks, Medtronic, Cerenovus, Apta Targets, Anaconda Biomed, Stryker, Johnson and Johnson, Perflow Medical, Sanofi, Rapid AI, Philips; grants: CVAid. MW – funding: Stryker Neur...
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: 14th Congress of the European Society of Minimally Invasive Neurological Therapy 2022 Meeting Abstracts Source Type: research